Therapeutic Agent Injection Device

Patent No. EP3572105 (titled "Therapeutic Agent Injection Device") was filed by Medtronic Minimed on Oct 9, 2014. The application was issued on Jun 9, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
CONVATEC	Mar 9, 2022	HGF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 25, 2023
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Aug 22, 2023
Termination of the opposition proceedings with maintenance of patent
May 17, 2023
Advice of delivery
May 11, 2023
Brief communication - Opposition proceedings
May 11, 2023
Brief communication - Opposition proceedings
May 11, 2023
Notification concerning the date of oral proceedings
May 5, 2023
(Electronic) Receipt
May 5, 2023
Letter accompanying subsequently filed items
May 5, 2023
Withdrawal of an opposition
Dec 13, 2022
Notification concerning the date of oral proceedings
Dec 13, 2022
Notification concerning the date of oral proceedings
Nov 24, 2022
(Electronic) Receipt
Nov 24, 2022
Advice of delivery
Nov 24, 2022
Letter accompanying subsequently filed items
Nov 2, 2022
Advice of delivery
Oct 28, 2022
Annex to the communication - opposition
Oct 28, 2022
Information concerning oral proceedings
Oct 28, 2022
Scanned annex to a communication - opposition procedure
Oct 28, 2022
Summons to attend oral proceedings
Oct 28, 2022
Summons to attend oral proceedings
Oct 28, 2022
Transmittal of decision / summons - opposition
Oct 28, 2022
Transmittal of decision / summons - opposition
Oct 21, 2022
Information about the result of oral proceedings
Sep 14, 2022
Brief communication - Opposition proceedings
Sep 9, 2022
(Electronic) Receipt
Sep 9, 2022
Letter accompanying subsequently filed items
Sep 9, 2022
Reply from the opponent to submission of proprietor
Jul 12, 2022
Brief communication - Opposition proceedings
Jul 7, 2022
(Electronic) Receipt
Jul 7, 2022
Letter accompanying subsequently filed items
Jul 7, 2022
Reply of the patent proprietor to the notice(s) of opposition
Apr 6, 2022
Communication confirming withdrawal from representation
Apr 6, 2022
Communication of amended entries concerning the representative
Mar 28, 2022
(Electronic) Receipt
Mar 28, 2022
(Electronic) Receipt
Mar 28, 2022
Letter accompanying subsequently filed items
Mar 28, 2022
Letter accompanying subsequently filed items
Mar 28, 2022
Request for change of opponent's representative
Mar 28, 2022
Request for change of opponent's representative
Mar 23, 2022
Communication of a notice of opposition and request to file observations
Mar 23, 2022
Notice of further oppositions to opponent(s)
Mar 15, 2022
Communication of a notice of opposition - first information to patent proprietor
Mar 9, 2022
(Electronic) Receipt
Mar 9, 2022
Citation in opposition procedure - 001
Mar 9, 2022
Citation in opposition procedure - 002
Mar 9, 2022
Citation in opposition procedure - 003
Mar 9, 2022
Consolidated list of cited opposition documents
Mar 9, 2022
Notice of opposition
Mar 9, 2022
Notice of opposition
Jun 22, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
May 14, 2021
Decision to grant a European patent
Apr 29, 2021
(Electronic) Receipt
Apr 29, 2021
Filing of the translations of the claims
Apr 29, 2021
French translation of claims
Apr 29, 2021
German translation of the claims
Dec 21, 2020
Bibliographic data of the European patent application
Dec 21, 2020
Communication about intention to grant a European patent
Dec 21, 2020
Intention to grant (signatures)
Dec 21, 2020
Text intended for grant (clean copy)
Dec 21, 2020
Text intended for grant (version for approval)
Nov 12, 2020
Examination started
Sep 10, 2020
Document concerning representation
Apr 30, 2020
Amended claims filed after receipt of (European) search report
Apr 30, 2020
Amended description filed after receipt of (European) search report
Apr 30, 2020
Amendments received before examination
Apr 30, 2020
Letter concerning fees and payments
Jan 24, 2020
Letter concerning the inventor
Dec 2, 2019
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Oct 30, 2019
Notification of forthcoming publication
Oct 16, 2019
Refund of fees
Oct 14, 2019
Communication regarding the transmission of the European search report
Oct 14, 2019
European search opinion
Oct 14, 2019
European search report
Oct 14, 2019
Information on Search Strategy
Oct 8, 2019
Invitation to indicate correct address of inventor
Oct 1, 2019
Letter which had not been notified
Sep 2, 2019
Communication to designated inventor
Sep 2, 2019
Communication to designated inventor
Sep 2, 2019
Communication to designated inventor
Sep 2, 2019
Communication to designated inventor
Jul 10, 2019
Abstract
Jul 10, 2019
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Jul 10, 2019
Claims
Jul 10, 2019
Description
Jul 10, 2019
Designation of inventor
Jul 10, 2019
Drawings
Jul 10, 2019
Request for grant of a European patent
May 12, 2015
Priority document (electronically transmitted)
May 12, 2015
Priority document (electronically transmitted)

EP3572105

MEDTRONIC MINIMED

Application Number: EP19185515A
Filing Date: Oct 9, 2014
Status: Granted And Under Opposition; May 11, 2021
Publication Date: Jun 9, 2021
External Links: Slate, Register , Google Patents

IP Verse

Therapeutic Agent Injection Device

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3572105